ANZ News
Also, I-MED will expand its deployment of 4DMedical's lung imaging tool across its network in Australia.
It has zoom, rotate, and annotate features to help specialists explain procedures to patients virtually.
The company has also launched a distribution unit in the United States.
Two variants of the Annalise CXR Edge products will be offered in Australia.
The AI platform can predict a person's risk of having a stroke or a heart attack in the next five years.
Their combined solution eliminates manual scheduling and paging.
The company develops a breakthrough device for detecting residual cancer tissues.
As part of a global trend for health insurers, the cornerstone investment in XT Ventures will further HCF's "deep pedigree in helping innovative startups".
The clinical trial with Huntsville Heart Center is expected to be completed by October.
Their first project will involve the use of AI contouring to cut time for planning radiation therapies.